Cargando…

《胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版)》解读之D-二聚体篇

The risk of perioperative venous thromboembolism (VTE) is pretty high in thoracic cancer patients. Perioperative VTE influences the recovery of patients after operation and quality of life in the future, even seriously leading to death. To strengthen the knowledge and attention of thoracic surgeons...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935032/
https://www.ncbi.nlm.nih.gov/pubmed/31874671
http://dx.doi.org/10.3779/j.issn.1009-3419.2019.12.05
_version_ 1783483502074789888
collection PubMed
description The risk of perioperative venous thromboembolism (VTE) is pretty high in thoracic cancer patients. Perioperative VTE influences the recovery of patients after operation and quality of life in the future, even seriously leading to death. To strengthen the knowledge and attention of thoracic surgeons on perioperative VTE in thoracic cancer patients, China National Research Collaborative Group on VTE in Thoracic Surgery released the edition of VTE prophalaxis in thoracic cancer patients: Chinese experts consensus in 2018. This article is to interpret the diagnostic value and risk prediction value of D-dimer in VTE in detail, and briefly introduce the role of other biomarkers in VTE of tumor patients. The consensus interpretation aims to deepen the understanding of thoracic surgeons on the clinical significance of D-dimer in VTE.
format Online
Article
Text
id pubmed-6935032
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-69350322020-01-09 《胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版)》解读之D-二聚体篇 Zhongguo Fei Ai Za Zhi 专家视点 The risk of perioperative venous thromboembolism (VTE) is pretty high in thoracic cancer patients. Perioperative VTE influences the recovery of patients after operation and quality of life in the future, even seriously leading to death. To strengthen the knowledge and attention of thoracic surgeons on perioperative VTE in thoracic cancer patients, China National Research Collaborative Group on VTE in Thoracic Surgery released the edition of VTE prophalaxis in thoracic cancer patients: Chinese experts consensus in 2018. This article is to interpret the diagnostic value and risk prediction value of D-dimer in VTE in detail, and briefly introduce the role of other biomarkers in VTE of tumor patients. The consensus interpretation aims to deepen the understanding of thoracic surgeons on the clinical significance of D-dimer in VTE. 中国肺癌杂志编辑部 2019-12-20 /pmc/articles/PMC6935032/ /pubmed/31874671 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.12.05 Text en 版权所有©《中国肺癌杂志》编辑部2019 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 专家视点
《胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版)》解读之D-二聚体篇
title 《胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版)》解读之D-二聚体篇
title_full 《胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版)》解读之D-二聚体篇
title_fullStr 《胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版)》解读之D-二聚体篇
title_full_unstemmed 《胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版)》解读之D-二聚体篇
title_short 《胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版)》解读之D-二聚体篇
title_sort 《胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版)》解读之d-二聚体篇
topic 专家视点
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935032/
https://www.ncbi.nlm.nih.gov/pubmed/31874671
http://dx.doi.org/10.3779/j.issn.1009-3419.2019.12.05
work_keys_str_mv AT xiōngbùèxìngzhǒngliúwéishùqījìngmàixuèshuānshuānsāizhèngyùfángzhōngguózhuānjiāgòngshí2018bǎnjiědúzhīdèrjùtǐpiān
AT xiōngbùèxìngzhǒngliúwéishùqījìngmàixuèshuānshuānsāizhèngyùfángzhōngguózhuānjiāgòngshí2018bǎnjiědúzhīdèrjùtǐpiān
AT xiōngbùèxìngzhǒngliúwéishùqījìngmàixuèshuānshuānsāizhèngyùfángzhōngguózhuānjiāgòngshí2018bǎnjiědúzhīdèrjùtǐpiān
AT xiōngbùèxìngzhǒngliúwéishùqījìngmàixuèshuānshuānsāizhèngyùfángzhōngguózhuānjiāgòngshí2018bǎnjiědúzhīdèrjùtǐpiān
AT xiōngbùèxìngzhǒngliúwéishùqījìngmàixuèshuānshuānsāizhèngyùfángzhōngguózhuānjiāgòngshí2018bǎnjiědúzhīdèrjùtǐpiān